In various studies related to non-alcoholic steatohepatitis, resistance to Adriamycin in breast cancer, and ischemic injury, Gsk3b and Aqp4 have been identified as direct target genes of miR-29a-3p [49,52,53]. This evidence concerns the gene GSK3B and metabolic dysfunction-associated steatohepatitis.